Beijing Tiantan Biological Products Corporation Limited provided earnings guidance for the first quarter of 2016. For the quarter, the company predicts that it will suffer a loss in its business performance, with its net loss owned by shareholders of listed company to be about RMB 0.7 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.3 CNY | -1.15% | -5.32% | -8.53% |
05-16 | Bank of China Executive Vice President Steps Down | MT |
05-02 | ICBC, CCB Name Deputy Party Secretaries | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.53% | 6.44B | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.50% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+5.32% | 8.82B |
- Stock Market
- Equities
- 600161 Stock
- News Beijing Tiantan Biological Products Co., Ltd.
- Beijing Tiantan Biological Products Corporation Limited Provides Earnings Guidance for the First Quarter of 2016